Manufacturing

The global cell culture vessels market is on a remarkable growth trajectory, projected to expand from an estimated USD 4.90 billion in 2023 to over USD 19.65 billion by 2033. This significant growth, at a robust CAGR of 14.9% from 2024 to 2033, underscores the critical role of cell culture

The gene therapy sector, once a beacon of hope for revolutionary treatments, has seen a significant slowdown in investment post the COVID-19 pandemic. This downturn follows a period of unprecedented financial influx during the pandemic years, raising questions about the future of this promising

South Korea's pharmaceutical and biotech industry is witnessing a fascinating shift as Contract Development and Manufacturing Organizations (CDMOs) and biosimilar developers are experiencing robust growth, while traditional pharmaceutical companies lag. At the forefront of this transition is

Thermo Fisher Scientific is making significant strides in the Indian biopharma market with the announcement of a new bioprocess design center (BDC) in Genome Valley, Hyderabad. This 10,000 square-foot facility, expected to open early next year, is part of a broader initiative by the company to

Fujifilm Diosynth Biotechnologies, a leading CDMO in the field of biologics, vaccines, advanced therapies, and oncolytic viruses, has embarked on the initial phase of a massive expansion project at their facility in Hillerød, Denmark. By adding six mammalian cell bioreactors to the existing

The biotechnology sector witnesses another strategic maneuver as private equity firms GHO Capital Partners and Ampersand Capital Partners have agreed to acquire Avid Bioservices for $1.1 billion. Avid, an influential contract development and manufacturing organization (CDMO), specializes in